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RESEARCH ARTICLE
Perspectives on self-managed abortion 
among providers in hospitals along the Texas–
Mexico border
Sarah Raifman1*, Sarah E. Baum2, Kari White3, Kristine Hopkins4, Tony Ogburn5 and Daniel Grossman1 
Abstract 
Background: Following self-managed abortion (SMA), or a pregnancy termination attempt outside of the formal 
health system, some patients may seek care in an emergency department. Information about provider experiences 
treating these patients in hospital settings on the Texas-Mexico border is lacking.
Methods: The study team conducted semi-structured interviews with physicians, advanced practice clinicians, and 
nurses who had experience with patients presenting with early pregnancy complications in emergency and/or labor 
and delivery departments in five hospitals near the Texas-Mexico border. Interview questions focused on respond-
ents’ roles at the hospital, knowledge of abortion services and laws, perspectives on SMA trends, experiences treating 
patients presenting after SMA, and potential gaps in training related to abortion. Researchers conducted interviews in 
person between October 2017 and January 2018, and analyzed transcripts using a thematic analysis approach.
Results: Most of the 54 participants interviewed said that the care provided to SMA patients was, and should be, the 
same as for patients presenting after miscarriage. The majority had treated a patient they suspected or confirmed had 
attempted SMA; typically, these cases required only expectant management and confirmation of pregnancy termina-
tion, or treatment for incomplete abortion. In rare cases, further clinical intervention was required. Many providers 
lacked clinical and legal knowledge about abortion, including local resources available.
Conclusions: Treatment provided to SMA patients is similar to that provided to patients presenting after early 
pregnancy loss. Lack of provider knowledge about abortion and SMA, despite their involvement with SMA patients, 
highlights a need for improved training.
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Introduction
Growing evidence suggests that some people in the 
United States (US) manage the termination of a preg-
nancy on their own outside of the health care system 
[1–6]. Patients who attempt self-managed abortion 
(SMA) often cite barriers to facility-based care as a moti-
vating factor [1], and the practice may be more common 
in states where access to abortion is highly restricted, 
such as Texas [2, 3]. A study of Texas abortion patients 
in McAllen, San Antonio, and Fort Worth conducted in 
2017–2018 found that 16%, 9%, and 15%, respectively, 
reported seeking or trying any method to end their preg-
nancy before going to the clinic [2]. Patients reported 
using the following SMA methods: herbs, medications 
including misoprostol, and homeopathic remedies [2]. 
In addition, evidence suggests that the number of online 
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requests for mifepristone and misoprostol increased 
when clinics were shut down early in the COVID-19 
pandemic [4]. SMA prevalence estimates are higher 
in Texas relative to a national 2014 study, which found 
that approximately 2% of US abortion patients have ever 
attempted SMA [5, 6]. The legal context around SMA is 
evolving in the US: as of 2019, there are roughly 40 laws 
that potentially could be used to prosecute someone who 
self manages an abortion with the support of an advocate 
or caregiver, and there have been 21 known arrests for 
SMA and criminal investigations in 20 states, including 
Texas [7]. Six states directly ban SMA as of 2019 (Idaho, 
Nevada, Arizona, Oklahoma, South Carolina, and Dela-
ware) [8].
A variety of factors may contribute to SMA being 
more common in Texas, and specifically in the Texas-
Mexico border region, relative to other US states. These 
include geographic proximity to Mexico where medica-
tions are generally inexpensive and less regulated than in 
the US [9]; the availability of misoprostol, a medication 
used for termination of pregnancy, without a prescrip-
tion in Mexican pharmacies [10]; the large population 
of immigrants from Latin America, where people have 
been using misoprostol for SMA in contexts where abor-
tion is legally restricted [11]; and the limited availability 
of facility-based abortion care in Texas. A qualitative 
study of Texas women with SMA experience found that 
those who used misoprostol had obtained it in Mexico 
[4]. Among other legal restrictions on abortion patients, 
providers, and facilities, Texas implemented House Bill 
2, one of the most restrictive abortion laws in the coun-
try, in 2013, which led to the closure of half the state’s 
abortion clinics [2, 12]. Perceived and experienced abor-
tion stigma among people seeking abortion in Texas, 
due to religious, cultural and political influences, also 
likely leads some to seek abortion outside of the for-
mal medical system. A desire to avoid stigma or shame, 
in addition to recommendations from friends or family 
members, are reported as reasons for attempting SMA 
in Texas [4]. A survey of Texas women age 18–49 found 
that 22% reported knowing someone who had attempted 
SMA; those more likely to report knowing someone who 
attempted SMA included Latinas living in a county bor-
dering Mexico and people reporting they faced financial 
or logistical barriers accessing reproductive health ser-
vices [13].
Historically, clinicians working in emergency depart-
ments (EDs) have had limited exposure to patients 
seeking care after a facility-based abortion. This is in 
part because complications are rare after abortion: one 
study in California of over 500,000 abortion patients in 
2009–2010 found that 0.9% visited an ED for an abor-
tion-related complication within 6 weeks of the abortion 
[14]. A national study found that 0.01% of all ED visits by 
women aged 15–49 in 2009–2013 were abortion-related, 
of which 51% required only observation without treat-
ment [15]. Patients who travel farther to access abortion 
services are more likely to seek care in an ED in case of 
a possible complication after returning home, suggesting 
that as facility-based abortion care becomes more dif-
ficult to access—or even non-existent in some states—
more patients may present to EDs for abortion-related 
care [16].
National data suggest that ED visits related to SMA in 
particular are even less common, representing 1.4% of 
abortion-related ED visits. Higher rates of SMA-related 
ED visits were documented in the South (2%) compared 
to the Midwest (1%), West (1.1%), and Northeast (1.3%) 
[15]. There are research gaps in our understanding of the 
provision of SMA-related treatment in the hospital set-
ting. Studies documenting significant barriers to pro-
viding miscarriage management in the ED suggest that 
SMA care may be similarly challenging [17]. Given the 
additional risk of criminalization faced by patients sus-
pected of attempting SMA, the limited experience ED 
providers historically have had managing these patients, 
and the changing policy environment that may lead to an 
increase in SMA, it is critical to explore the perspective 
of clinicians who may care for these patients in urgent 
care settings. For some who try SMA, ED providers 
may be the only point of contact with the medical sys-
tem; therefore, ED providers are well-positioned to pro-
vide insight into SMA trends and experiences of patients 
who seek hospital care, which could inform guidance to 
improve their care.
The aim of this exploratory study was to document 
hospital provider perspectives of SMA, the care provided 
to patients who present to the ED after attempting SMA, 
and provider preparedness to respond to these patients. 
We explored these questions through interviews with 
providers who had experience treating patients who pre-
sented with early pregnancy complications in hospital 
settings, including the ED and labor and delivery (L&D), 
to document their experiences with patients presenting 
after possible SMA. ED and L&D provider perspectives 
can offer new insight into SMA trends and the needs of 
patients and providers as facility-based abortion care 
becomes increasingly more restricted in Texas.
Methodology
To capture a diversity of perspectives among providers 
with experience treating patients with early pregnancy 
complications, we recruited and interviewed physicians, 
advance practice clinicians (APCs), and nurses who 
worked in the ED and/or L&D at five hospitals in Texas 
near the Mexican border in October 2017 and January 
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2018. We chose this study population to enable the inves-
tigation of not only experience managing SMA and sus-
pected SMA, but also gaps in preparedness, training, and 
resources available to providers who treat patients pre-
senting after potential SMA. We identified recruitment 
hospitals along the border based on interest in the study 
among providers and administrators across the region. 
These contacts assisted us in obtaining institutional 
approval for the study and in identifying eligible partici-
pants. We included providers working in L&D settings 
after learning early in the study that some cases of sus-
pected SMA—particularly those later in gestation—were 
sometimes managed in the obstetrical unit, including 
L&D or an obstetrics triage, rather than the ED setting.
Initial efforts to remotely recruit participants for phone 
interviews using departmental announcements and email 
listservs were not effective. We conducted two pilot 
interviews by telephone, after which we edited the inter-
view guide to improve clarity and add probing questions 
related to key themes. We excluded these pilot interviews 
from analysis. In our revised recruitment strategy, three 
researchers trained in qualitative data collection visited 
sites to recruit and interview participants in person. At 
each hospital, the primary contact initially informed 
their colleagues about the study and invited them to go 
to a private room where the researchers were conduct-
ing interviews to schedule an interview if they were 
interested in participating. We also employed a snowball 
sampling approach: after participants completed their 
interview, we encouraged them to inform eligible col-
leagues about the study. The study did not provide incen-
tives for participation.
Providers were eligible to participate if they worked at 
any of the five study hospitals and had experience with 
patients presenting with early pregnancy complica-
tions in the ED or L&D. Eligible participants provided 
informed consent to conduct and audio-record the inter-
view. At each site, we conducted as many interviews as 
possible over the course of two or three days. We aimed 
to complete 50 interviews with perspectives from five 
hospitals. We conducted the research in accordance 
with the relevant guidelines and regulations after obtain-
ing ethical approval from institutional review boards 
at the University of California, San Francisco and The 
University of Texas at Austin and official administrative 
approval from each hospital site.
As one of the first studies to explore this topic with 
ED and L&D providers, it was exploratory. The inter-
view guide and analysis were grounded in the existing 
literature around SMA and miscarriage management [4, 
17–19]. Semi-structured interview questions focused on 
the respondent’s clinical experience, role at the hospital, 
primary patient population, knowledge of local abortion 
services and relevant state laws, perspective on trends 
in SMA, experience with care provided to patients pre-
senting after a potential SMA attempt, and perceived 
gaps in training related to SMA. Interviewers also asked 
participants about specific cases in which patients had 
attempted SMA, including the patient’s clinical presenta-
tion, weeks’ gestation, methods used, treatment, outcome 
and complications, as well as the challenges the provider 
may have faced treating the patient, lessons learned about 
the experience, and personal feelings about SMA and/
or abortion. The length of interviews varied to accom-
modate hospital flow and providers’ time constraints. 
For providers who had limited time, the interviewers 
prioritized key topics in the interview guide includ-
ing SMA trends and experience treating SMA patients. 
The research team also collected minimal demographic 
information from providers at the end of the interviews, 
including their age, gender, race, and ethnicity.
The interviewers reviewed the professionally tran-
scribed interviews to ensure consistency with the 
recalled encounter and the audio recording as needed 
and to redact any identifying information. The research 
team developed a preliminary codebook based on recur-
ring patterns they identified during the interview pro-
cess. Using Dedoose [20], three researchers trained in 
qualitative coding and analysis independently coded a 
subset of interviews using the preliminary codebook and 
then compared their respective applications of the codes, 
discussed inconsistencies, resolved differences through 
consensus, refined the codebook, and applied the revised 
codebook to a new subset of transcripts. This process was 
repeated three times until the researchers agreed on a 
final codebook. The coders met regularly to discuss any 
new themes that emerged and, through consensus, added 
them to the codebook. Once there was concordance, two 
coders independently applied the final codebook to all 
transcripts. The first author then used a matrix to ana-
lyze patterns in the data [21] and repeatedly revisited the 
transcripts to ensure that codes were applied to all rel-
evant text and that all key themes were included in the 
matrix. Below, we summarize major themes and identify 
participants by their respective roles (physician, APC, or 
nurse) and departments (ED or L&D) at the time of the 
interview.
Results
We completed 57 interviews at five hospitals and omit-
ted three incomplete interviews (defined as shorter than 
ten minutes), which did not include relevant experience 
with SMA. The final analysis included 54 interviews 
between ten minutes and one hour in length. One-third 
of respondents in the sample were physicians (n = 18) 
and two-thirds served in other clinical roles, primarily 
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as  nurses (Table  1). Nearly two-thirds held positions in 
L&D and one-third in the ED, though some providers 
served in both departments. The type of providers inter-
viewed was not equally distributed across hospital sites, 
likely due to use of snowball recruitment methods: two 
of the sites included only physicians or only nurses. The 
majority of participants self-identified as female (n = 37, 
69%) and Hispanic (n = 35, 65%). One-third of providers 
were in their 30s (n = 18, 33%), with the remainder split 
between their 20s (n = 12, 22%), 40s (n = 11, 20%), and 
50 years or older (n = 10, 19%).
We describe four main themes that emerged: trends in 
SMA  patient characteristics and trends; treatment pro-
tocols for suspected SMA patients; involvement of social 
workers or police in suspected SMA cases; and provider 
knowledge about abortion and gaps in training for treat-
ment of SMA patients.
Provider perception of SMA patient characteristics 
and trends
In general, respondents indicated that most patients they 
suspected of SMA were early in gestation, young, pre-
senting for care on their own, and had minimal resources, 
including no health insurance. An ED physician noted, 
“Well they’re usually in the early first trimester. Any-
where between four and eight weeks I would say on aver-
age. And they present with bleeding and cramping. …
they’re usually young. But not always. I mean they’re typ-
ically between 18 and 24 or younger…. Although I have 
seen a couple of patients that were older than that. They 
usually show up alone.”
Another physician who worked on L&D recalled that 
many of the SMA patients seen at the hospital were origi-
nally from Mexico: “Most of them were undocumented, 
but had formed a life over here in [city], but for certain 
issues, they couldn’t establish care, monetary issues to 
get the abortion, so they went to Mexico or had a fam-
ily member go to Mexico and obtain some medication for 
them.”
Providers’ anecdotal estimates of the frequency of see-
ing patients suspected of SMA in the hospital  ranged 
from one case per month to 10 cases in 20  years. The 
majority of providers reported first-hand experience 
treating patients who attempted SMA, while others had 
only heard about SMA happening in the community. Of 
the 54 respondents, 38 (70%) recalled at least one case of 
suspected SMA in which they were personally involved.
Providers reported a range of responses regarding SMA 
trends in the community. At one facility, two respondents 
perceived recent increases in SMA; an ED nurse said: “I 
think that we have more [SMA] cases now. I think that 
part of it might have been the fact that we don’t—it’s 
harder to get access to abortion here under a doctor’s 
care, as opposed to what it was before…I think that may 
be part of it.” An ED physician who worked in the same 
hospital also noted “seeing an upsurge” in SMA cases. 
When asked about when this change occurred, they said: 
“…since the internet provided information about what 
Cytotec is, how available it is, and because we are a bor-
der area it’s fairly available and most patients will have a 
grandmother who’s on Cytotec for ulcer treatment or GI 
discomfort, or that sort of thing. It’s relatively cheap.”
In contrast, two providers who had been working in the 
region for over two decades each said they thought SMA 
was less common now than it was in the past. One of 
these providers, an L&D nurse, explained: “I haven’t seen 
it since I’ve been back [to the region] this time. I used to 
Table 1 Participant characteristics
Proportions may not add up to 100% as a result of rounding
Participant characteristics (n = 54)
Clinical role n (%)
  Physician 18 (33%)
  Advanced Practice Clinician (APC) (nurse practitioner, 
physician’s assistant)
4 (8%)
  Nurse (Registered nurse, licensed vocational nurse) 32 (59%)
Department
 Emergency 20 (37%)
 Labor and delivery 34 (63%)
Sex
 Female 37 (69%)
 Male 17 (32%)
Age
 < 30 years 12 (22%)
 30–39 years 18 (33%)
 40–49 years 11 (20%)
 ≥ 50 years 10 (19%)
 Missing 3 (6%)
Hispanic/Latin origin
 Yes 35 (65%)
 No 14 (26%)
 Missing 5 (9%)
Number of SMA cases discussed
 0 16 (30%)
 1 27 (50%)
 2 10 (19%)
 3 1 (2%)
Facility
 Hospital 1 13 (24%)
 Hospital 2 8 (15%)
 Hospital 3 15 (28%)
 Hospital 4 10 (19%)
 Hospital 5 8 (15%)
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work here in 1994,’95,’96, and we had several women that 
came in after they had taken Cytotec because you can get 
that in Mexico.”
Treatment protocols for suspected SMA patients
Overall, providers reported that they were clinically 
prepared to treat SMA patients primarily because SMA 
treatment requires the same knowledge and skills as 
miscarriage management. Respondents described SMA 
patients as having similar presentation as those expe-
riencing early miscarriage and then receiving either 
treatment for incomplete abortion (typically vacuum 
aspiration) or expectant management (observation with-
out treatment) at the ED and/or L&D. An L&D physician 
explained a common presentation: “Typically [patients] 
come in because they started the process, maybe they 
don’t realize what it entails, so then they kind of get wor-
ried because they start cramping and bleeding a lot. So 
they’ll come to the ED. So, a lot of times it’s just reassur-
ance that, you know, what they’ve done—this is just part 
of the process.”
Most participants said they had not witnessed any com-
plications related to SMA; however, a handful reported 
cases that required additional treatment, such as dilation 
and curettage for retained placenta or a blood transfu-
sion, or monitoring of their continuing pregnancy after 
attempting SMA. Respondents indicated that the type of 
cases they saw in the hospital were likely not representa-
tive of typical SMA experiences. For example, an L&D 
physician said, “We’ve only seen the grave complications. 
I’m sure there’s a lot of patients that successfully do self-
induce with misoprostol from Mexico that we don’t even 
hear about.” An ED nurse at a different hospital agreed 
with this sentiment, “The few we do see are the ones that 
weren’t lucky, and they ended up sick because of it.”
When asked about the type of care provided to patients 
presenting after a possible SMA, the majority of par-
ticipants explained that it was no different from the care 
provided to any pregnant patient presenting with bleed-
ing or signs of early pregnancy complications. Most pro-
viders said they did not typically inquire about pregnancy 
intention or about whether a patient had done something 
to try to end the pregnancy on their own, and if they did, 
it did not affect their clinical decision-making. An L&D 
nurse said, “We’re nurses here, we’re going to care for 
them whether they wanted to keep their baby or really 
lost their baby or really didn’t want to have nothing to do 
with the baby. Our care is the same.” This was echoed by 
other nurses.  Another L&D nurse at the same hospital 
said: “they’re not really treated differently than some-
one who comes with a spontaneous miscarriage.” An ED 
nurse at a different hospital said: “It doesn’t change any-
thing. I was like, if you took the pills, you didn’t take the 
pills, who cares? Like, we’re going to medically screen 
you, treat you, and then send you on your way. Or admit 
you if you need to be admitted. [Our care] has nothing to 
do [with whether] you took pills or not.”
Some providers reported having asked about whether a 
patient had done something to terminate the pregnancy, 
but that asking was by no means part of a standard pro-
tocol. Instead, providers referenced noticing something 
that made them ask about a patient’s potential SMA 
attempt or pregnancy intention. For example, an L&D 
nurse explained, “…you notice things, discrepancies in 
their stories, and you try to dig a little bit more… that’s 
when you start catching on that something’s not right 
with this story…but once they get that information out, 
we don’t do much else.” The majority of those who said 
they ask about pregnancy intention indicated that their 
motivation was to better understand the patient’s social 
situation in order to refer them as needed to additional 
services; none said that the information was necessary to 
provide better clinical care for the patient.
Reflections on reporting suspected SMA cases
In addition to providing the same care to all patients 
presenting with pregnancy complications, regardless of 
SMA attempts, more than half of the providers also felt 
that there was no need to report suspected SMA cases 
to the police or other authority. None of the respond-
ents knew of policies or guidelines for reporting specific 
to suspected SMA, and most said that the decision to 
report such cases was subject to provider discretion. An 
ED physician said: “To my knowledge, there’s no report-
ing, per se, that needs to be done. From the medical/
legal standpoint there’s… I mean, like I said, lawfully, ter-
mination of pregnancy is a lawful act. So I don’t see any 
reporting that needs to be reported. And, to my knowl-
edge, there is no law that says we have to, you know, call 
any state agency, etcetera.” An L&D nurse explained, “It’s 
kind of either the provider or the nurse [who] makes that 
decision…a lot of times, [patients] won’t tell the provider 
certain things, and they’ll mention things to us, and we’re 
like, okay, we need to find out about that.” This provider 
continued on to offer some examples of when they might 
call social services to further support the patient, includ-
ing if the patient has suicidal tendencies or problems at 
home, such as lack of supplies or resources to care for the 
baby should the pregnancy continue.
Several respondents recalled a suspected SMA case 
where social workers were asked to participate in the 
patient’s care, which sometimes led to the involvement 
of Child Protective Services (CPS)  or the police. Two 
broader categories of circumstances led to the involve-
ment o social workers: protecting patients against possi-
ble coercion or abuse and reacting to potential harm to a 
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viable fetus. This comment from an L&D nurse illustrates 
the first category, “If the person is a minor or homeless 
or maybe doesn’t have transportation, any kind of abuse 
issue…[social work may become involved] to see if there’s 
any issues that will present to the woman when she gets 
home.” Another L&D nurse at a different hospital dis-
cussed involving social workers in the case of a patient 
from Central America who presented at 20 weeks’ gesta-
tion after having taken pills multiple times to terminate 
the pregnancy. When asked for the primary reason social 
workers were called, the nurse said: “Because we found 
out it wasn’t the first time that she had taken the pills…
we started trying to dig and find out ‘hey, what’s going 
on? And why would you want to?’ you never know; it 
could have been a rape here? If it was a rape that hap-
pened to them as they were traveling, there’s not a lot we 
can do, but if it’s something that’s going on here? Then 
we can escalate that and try to get our authorities, or 
whatever it is we need to do.” Sometimes concern about 
a viable fetus was used to justify the involvement of social 
workers, particularly if the patient was beyond the first 
trimester in pregnancy. One L&D physician likened the 
situation to drug use in pregnancy, suggesting that SMA 
attempts after 20  weeks’ gestation justified the involve-
ment of social workers.
Two of the reported cases in which the police were 
notified involved patients who were minors. An ED 
nurse, who was working in the unit at the time the 
patient presented but was not directly involved in the 
case, believed the police were called because the minor 
had reportedly purchased medications used to terminate 
the pregnancy at school. The provider said: “We had to 
call case management. Case management has to inform 
police. And she gave the name of her friend who gave 
it, and they had to go to the school and talk to her also. 
They also had to talk to the mother. I think in that case, 
because it involved a school—it came from the school—
so I think that’s why they had to call the police to let them 
know, so she won’t bring more to the school and give it 
to, you know, other kids.”
In the case of another minor, the provider involved the 
police because of possible partner coercion. The patient 
had attempted SMA unsuccessfully throughout her preg-
nancy and was seen again in the ED at 31 weeks’ gesta-
tion after taking pills she had purchased in Mexico. She 
was accompanied by her boyfriend, who was married, 
and the providers had the impression that it was he, not 
she, who did not want the pregnancy to continue. The 
provider, an ED nurse, explained: “In this case, CPS just 
got involved because of the abuse that [her partner] had 
made her do it, but she was not willing to file any charges 
against him. So, the police officer could not hold him. 
CPS only gets involved usually if there’s any kind of abuse 
or if she were to have any issue to come back positive for 
any drugs, which she was negative for.”
A minority of providers said they were against abortion 
in general and that they would be in favor of reporting 
patients who attempted SMA, particularly at later gesta-
tions. One of these was an ED nurse who explained, “I 
would definitely like to see the policy change, that if [the 
fetus is] viable that it’s against the law, and that there be 
some criminal back-up for the patient to where some-
thing happened to her.”
Training needs related to SMA and abortion
As discussed above, nearly all providers reported being 
clinically equipped to manage the treatment of patients 
presenting with pregnancy loss and associated compli-
cations, including related to SMA. However, several key 
gaps in preparedness for responding to the needs of SMA 
patients remained. Several providers, mainly nurses, 
revealed a lack of basic knowledge about the safety, side 
effects, and potential complications of the medication 
abortion process. For example, an ED nurse said, “I don’t 
think [patients] understand the severity of that pill. The 
side effects… I can’t remember what it is…bleeding and 
pain and nausea and vomiting… the overnight pill to 
abort.” Another ED nurse acknowledged their own lack of 
information about medication abortion, “…I don’t know 
what [the abortion pill] is called. I think it’s like… it’s just 
a more intense, or higher dosage of a Plan B, right? …I 
don’t really know how else you would do it. I’m sure you 
can make it happen.”
Nearly all providers knew abortion was not offered 
in their hospital, yet few knew where or how to refer 
patients for abortion and postabortion care in the com-
munity. An ED nurse asked, “Are [abortions] available? I 
don’t think so… is there a clinic out there … I don’t know” 
(ED nurse). Confusion and misinformation about SMA 
legality was even more pervasive. It appeared that most 
providers had never considered whether SMA was illegal, 
though some explained they assumed it was, and were 
uncertain about when and to whom to report SMA cases. 
An ED physician who had been conflicted whether or not 
to report a patient said, “I wish I did know [about] laws 
or policies related to SMA… I don’t know the actual laws 
about it. I mean I assumed [SMA] was illegal, because it’s 
not under the supervision of a physician.”
Providers not only lacked formal training in abortion 
care but were also ill-equipped to provide comprehen-
sive counseling and resources to patients about family 
planning and pregnancy options more broadly. Several 
providers expressed interest in becoming better trained 
to support the emotional needs of their patients and pro-
vide options counseling, resources, and information for 
those seeking family planning, adoption, abortion, or 
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postabortion care. An ED nurse explained: “[Abortion] 
is not even part of our program, like, hey, if we see this, 
what can we give them? There’s not a doctor you can 
refer them to. … There’s nothing for them. You know, and 
it’s sad, too, because it’s like a 20-year-old who comes and 
doesn’t want to have a child, and now you hear people 
say, ‘Well, she shouldn’t have had sex.’ …And I feel like 
that’s terrible.”
A few providers acknowledged that it would be helpful 
to learn about SMA in particular, even if they do not plan 
to be involved in abortion care directly. For example, an 
L&D physician said: “I feel that we need more training. I 
feel that even if you’re not going to provide abortion ser-
vices… that I should be prepared to talk to my patients 
about their different options and be able to counsel my 
patients objectively.” Similarly, an ED nurse said there is a 
gap in training on support services for SMA patients and 
in understanding how their counseling needs may differ 
from those of patients undergoing a spontaneous miscar-
riage. She explained: “You know, we get a lot of training 
about bereavement and if she comes in with like a fetal 
demise or a pregnancy loss to provide comfort and that 
kind of side of it. But we don’t really get anything more 
specific to a self-terminated pregnancy. …Kind of like 
a different set of training but around a similar—around 
pregnancy loss.”
Several providers reflected on whether it was within the 
scope of work of an ED provider to counsel SMA patients, 
implying that the ED provider’s primary responsibility is 
typically to meet the acute medical needs of the patient. 
In general, providers said they did not need additional 
training on medical management of incomplete abortion 
or more serious complications related to pregnancy loss 
in order to adequately meet the needs of their patients. 
A physician who worked in the ED said, “…I don’t know 
if it’s necessarily the role of the ER [to counsel patients]. 
As for the medical aspect of it, we’re absolutely equipped 
for it—we do it every day. But the social aspect of it—
we’re not really equipped.” Related to this, a few provid-
ers recommended better referral systems between the ED 
and L&D hospital units for patients who have miscarried 
or attempted SMA. This sentiment was echoed by both 
L&D and ED providers. An L&D physician commented: 
“I actually was hoping that up in L&D, where we exclu-
sively see nothing but pregnant patients, that perhaps we 
can also see all pregnant patients, regardless of their ges-
tation, up in L&D. I believe that would be a better envi-
ronment for the patient. There’s L&D nurses that are well 
trained in vaginal exams and … I believe maybe we’re just 
in that better mindset to deal with the emotional and the 
psychological issues that come with a pregnant patient.” 
An ED nurse similarly explained: “… that would be really 
nice to have, even if someone from L&D came down and 
talked to [the patients]. …I would love to have them more 
involved with us in these sort of cases.”
Discussion
These hospital provider experiences give insights into 
the presentation and clinical course of patients attempt-
ing SMA who obtained care at hospitals along the Texas-
Mexico border and how decisions are made regarding 
their care. Overall, respondents reported seeing SMA 
cases in the hospital, but not necessarily in increas-
ing numbers. Most providers agreed that SMA patients 
should receive the same care as any patient experienc-
ing pregnancy loss, but they had less certainty about 
reporting. This study supports prior quantitative find-
ings, which indicate that SMA patients seek hospital care 
and that most abortion-related ED visits require only 
observation care without treatment [14, 15]. Ralph et al. 
found that less than one-third of a large nationally rep-
resentative sample of women ages 18–49 reported that 
their SMA method worked to end the pregnancy, 11.4% 
reported miscarrying later in pregnancy, and a total of 
11% reported experiencing a complication requiring 
treatment by a physician or nurse. Our findings related to 
uncertainty around SMA reporting and a lack of provider 
knowledge about abortion legality and resources point 
to opportunities for improved hospital provider training 
to ensure that SMA patients get the care they need. This 
is supported by prior research on the challenges of pro-
viding miscarriage care in the ED, including the similar-
ity between abortion and miscarriage management and 
limited capacity to address emotional aspects of the care 
[17]. Perspectives on treatment of SMA in the hospital 
setting are particularly useful given restrictions that may 
limit access to facility-based abortion care in the border 
region and beyond.
Hospital providers in the border region appeared to 
be equipped to meet the clinical needs of SMA patients, 
given that SMA patients often have similar clinical pres-
entations as patients with pregnancy loss [22, 23]. But 
appropriate comprehensive care for SMA patients in the 
hospital setting also requires that providers be able to 
manage SMA with medications, to identify when use of 
expectant management is reasonable, to recognize poten-
tial complications of unsafe methods, to provide rele-
vant counseling and information, and to limit or reduce 
patients’ risk of criminalization [23]. With increased 
access to mifepristone and misoprostol through infor-
mal markets and less use of dangerous SMA methods, 
the potential clinical risks associated with SMA are likely 
to be low. Though evidence is limited, studies show that 
people can use medication abortion safely on their own 
with minimal supervision [23–25].
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Comprehensive and compassionate postabortion care 
is also important in the hospital setting for the treat-
ment of patients following an SMA attempt. The five 
essential elements of quality postabortion care, as recom-
mended by The World Health Organization, include: (1) 
prevention of unsafe abortion through community and 
service provider partnerships, (2) timely identification 
and response to women’s emotional and physical health 
needs, (3) treatment of incomplete and unsafe abortion 
and complications, (4) provision of family planning and 
contraceptive services, and (5) referral to reproductive 
and other health services as needed [26]. According to 
Dickens et  al. 2019, it is not only appropriate to apply 
postabortion care to the context of SMA, it is part of the 
professional, ethical and legal duties of all providers [27]. 
Importantly, the World Health Organization framework 
does not take into account the risk of criminalization 
faced by patients in the US [23]. Based on the present 
study’s findings, two essential elements of postabortion 
care may be in need of improvement in the hospital set-
ting in particular. These include: timely identification and 
response to women’s emotional and physical health needs 
and referral to reproductive and other health services as 
needed [26]. Similar to findings from Dennis et  al. on 
miscarriage management in the ED [17], most hospital 
providers in this study were not equipped to meet the 
emotional as well as physical needs of their patients in the 
context of SMA, including being aware of and sensitive 
to abortion stigma and potential legal risks to the patient 
of reporting SMA. In addition, this study revealed that 
the presence of abortion stigma in the hospital setting 
was perpetuated by some providers, which could lead to 
diminished care quality. Particularly in the border region, 
some patient characteristics, such as immigration status 
and income level, may put patient health and wellbeing at 
additional risk if police are unnecessarily involved. Many 
providers lacked awareness of the availability of abor-
tion services in the region and were unprepared to meet 
the counseling needs specific to SMA patients, includ-
ing providing accurate referral resources and informa-
tion about the legality of SMA and abortion. This may 
be partially explained by the fact that nurses comprised 
the majority of the sample, and nurses tend to have lower 
levels of knowledge about clinical and legal aspects of 
abortion relative to their physician counterparts [28].
Findings from the present study suggest that providers, 
particularly those who are unaware of abortion and SMA 
legality, may report potential SMA cases to the police 
unnecessarily, perhaps due to concerns about liability 
in the context of a highly litigious medical system. Care 
can usually be given without knowledge of whether the 
abortion is self-managed or spontaneous [23] and, in the 
case that one does learn of a patient’s SMA attempt, no 
state currently requires healthcare providers to report 
SMA, even when the patient is a minor. Hospital clini-
cians must be aware of the potential risk to patients’ 
legal safety of involving  CPS or police in suspected SMA 
cases. The involvement of police in cases of pregnancy 
complications, including miscarriage, can result in the 
detention and prosecution of individuals [29]. Laws or 
practices that criminalize SMA may put patients experi-
encing pregnancy complications (related or unrelated to 
SMA) at medical risk by discouraging them from seeking 
care when they need it [30]. Reporting is also problem-
atic because caregivers are more likely to report patients 
of color and low-income patients than white or affluent 
patients in similar circumstances [31]. Leading national 
medical organizations oppose the prosecution and pun-
ishment of pregnant women who use substances [32–34], 
including for the purposes of SMA [35]. The American 
College of Obstetricians and Gynecologists (ACOG) has 
explicitly stated that forcing physicians to share informa-
tion about their patients, including related to a potential 
SMA attempt, jeopardizes the patient-provider relation-
ship [35, 36].
This study has several limitations. Participants dis-
cussed SMA cases that occurred at any point in their 
hospital career and therefore were subject to recall bias. 
It is possible that providers were more likely to remem-
ber the SMA cases that required intervention relative to 
those that required only routine miscarriage manage-
ment. In order to address this, we have only included 
in the analysis the cases for which providers stated or 
implied that they were involved directly in the patient’s 
care. Another limitation is that we did not interview 
social workers at the hospitals who were involved in the 
decision to include authorities in SMA cases, so we are 
not able to present their direct experiences or decision-
making protocols except through the perspectives of 
providers. Provider perspectives on SMA may vary by 
provider type, hospital, and hospital department; how-
ever, this study was not designed to investigate these sub-
group differences. Finally, these data cannot be used to 
estimate the prevalence of SMA, treatment methods, or 
complications at these sites, or to represent the impor-
tant perspectives of patients or providers outside of the 
border region—all of which are aims that were outside 
of the scope of this study. In future research, quantitative 
data are needed to understand SMA trends, prevalence 
of SMA complications, and prevalence of hospital treat-
ment for SMA complications. Despite its limitations, this 
is one of the first studies to investigate hospital provider 
perspectives on SMA.
The qualitative findings presented here contribute to 
a nuanced understanding of the range of types of SMA 
cases that hospital providers along the Texas-Mexico 
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border encounter and the treatment they provide. While 
the findings are not generalizable beyond Texas, or the 
Texas-Mexico border region specifically, facility-based 
abortion care is being restricted in many states across the 
US, which may prompt more patients to attempt SMA. 
Because people who attempt SMA, and those suspected 
of having attempted SMA, have been criminalized, it is 
important that hospital-based providers have appropri-
ate training and preparation on the clinical care and legal 
protections these patients require.
Abbreviations
APC: Advanced Practice Clinician; ED: Emergency Department; L&D: Labor & 
Delivery; SMA: Self-managed abortion; CPS: Child Protective Services.
Acknowledgements
We acknowledge the support of our colleagues at each hospital site, who 
assisted us in obtaining administrative approval, recruiting participants, and 
conducting interviews. We also acknowledge Sofia Filippa, who assisted in 
the coding of transcripts. This study was performed as part of the Texas Policy 
Evaluation Project.
Authors’ contributions
SR and SB recruited participants, conducted interviews, and developed the 
codebook. SR led the coding and analysis of transcripts and drafted the 
manuscript. SB provided key input to analysis and interpretation of data. TO 
identified hospital sites, facilitated administrative contacts, obtained adminis-
trative approvals for the study, and provided key insight in the interpretation 
of results. DG designed the study, provided guidance in the data analysis and 
interpretation phases, and assisted in writing the manuscript. KW provided 
insight into the interpretation of results and assisted in writing the manuscript. 
KH assisted in the interpretation of data analysis and in revising and editing 
the manuscript. All authors provided editing and revisions to the manuscript 
and read and approved the final manuscript.
Funding
This study was funded by The Susan Thompson Buffett Foundation. The 
funder had no role in the collection, analysis, and interpretation of data or in 
writing the manuscript.
Availability of data and materials
The datasets generated and/or analyzed during the current study are not 
publicly available due to privacy and confidentiality concerns but are available 
from the corresponding author on reasonable request.
Declarations
Ethics approval and consent to participate
This study was performed in accordance with the Declaration of Helsinki and 
approved by the institutional review boards of the University of California, San 
Francisco and The University of Texas at Austin, and we also received formal 
approval from each hospital. Informed consent to participate in the study was 
obtained from all participants.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Author details
1 Advancing New Standards in Reproductive Health (ANSIRH), Department 
of Obstetrics, Gynecology & Reproductive Sciences, University of California, 
San Francisco, 1330 Broadway, Suite 1100, Oakland, CA 94612, USA. 2 Ibis 
Reproductive Health, 1736 Franklin St, Suite 600, Oakland, CA 94612, USA. 
3 Steve Hicks School of Social Work, The University of Texas at Austin, 1925 
San Jacinto Blvd, Stop D3500, TX 78712 Austin, USA. 4 Population Research 
Center, The University of Texas at Austin, 305 E. 23rd St. Stop G1800, Austin, 
TX 78712-1699, USA. 5 University of Texas Rio Grande Valley, 2102 Treasure Hill 
Blvd, Harlingen, TX 78550, USA. 
Received: 16 November 2020   Accepted: 12 March 2021
References
 1. Grossman D, Holt K, Peña M, et al. Self-induction of abortion among 
women in the United States. Reprod Health Matters. 2010;18(36):136–46.
 2. Aiken ARA, Broussard K, Johnson DM, et al. Knowledge, interest, and 
motivations surrounding self-managed medication abortion among 
patients at three Texas clinics. Am J Obstet Gynecol. 2020;223(2):238-e1.
 3. Aiken ARA, Starling JE, van der Wal A, et al. Demand for self-managed 
medication abortion through an online telemedicine service in the 
United States. Am J Public Health. 2020;110(1):90–7.
 4. Fuentes L, Baum S, Keefe-Oates B, et al. Texas women’s decisions and 
experiences regarding self-manage abortion. BMC Women’s Health. 
2020;20(6):1–12.
 5. Jones RK. How commonly do US abortion patients report attempts to 
self-induce? Am J Obstet Gynecol. 2011;204(1):23.
 6. Jerman J, Jones RK and Onda T, Characteristics of U.S. abortion patients 
in 2014 and changes since 2008. New York: Guttmacher Institute. 2016. 
https:// www. guttm acher. org/ report/ chara cteri stics us- abort ion- patie 
nts- 2014.
 7. The SIA Legal Team. Roe’s unfinished promise: decriminalizing abortion 
once and for all. 2018. https:// www. ifwhe nhow. org/ resou rces/ roes- unfin 
ished- promi se/. Accessed Jan 2021
 8. The SIA Legal Team. Roe’s unfinished promise: decriminalizing abortion 
once and for all. Updated spring 2019. https:// www. ifwhe nhow. org/ resou 
rces/ roes- unfin ished- promi se- 2019- update/. Accessed Jan 2021.
 9. Guzman GC, Khaleghi M, Riffenberg RH, Clark RF. A survey of the use 
of foreign-purchased medications in a border community emergency 
department patient population. J Emerg Med. 2007;33(2):213–21.
 10. Lara D, García SG, Wilson KS, et al. How often and under which circum-
stances do Mexican pharmacy vendors recommend misoprostol to 
induce an abortion? Int Perspect Sex Reprod Health. 2011;37(2):75–83.
 11. Zamberlin N, Romero M, Ramos S. Latin American women’s experiences 
with medical abortion in settings where abortion is legally restricted. 
Reprod Health. 2012;9(34):1.
 12. Grossman D, Baum S, Fuentes L, et al. Change in abortion services 
after implementation of a restrictive law in Texas. Contraception. 
2014;90(5):496–501.
 13. Grossman D, White K, Fuentes L, et al., Knowledge, opinion and experi-
ence related to abortion self-induction in Texas. Texas policy evaluation 
project: research brief. Presented at the North American Forum on Family 
Planning, Chicago, November 14, 2015. https:// liber alarts. utexas. edu/ 
txpep/_ files/ pdf/ TxPEP- Resea rch- Brief- Knowl edgeO pinio nExpe rience. pdf.
 14. Upadhyay UD, Desai S, Zlidar V, et al. Incidence of emergency depart-
ment visits and complications after abortion. Obstet Gynecol. 
2015;125(1):175–83.
 15. Upadhyay UD, Johns NE, Barron R, et al. Abortion-related emergency 
department visits in the United States: an analysis of a national emer-
gency department sample. BMC Med. 2018;16(1):88.
 16. Upadhyay UD, Johns NE, Meckstroth KR, Kerns JL. Distance traveled 
for an abortion and source of care after abortion. Obstet Gynecol. 
2017;130:616–24.
 17. Dennis A, Fuentes L, Douglas-Durham E, Grossman D. Barriers to and 
facilitators of moving miscarriage management out of the operating 
room. Perspect Sex Reprod Health. 2015;47(3):141–9.
 18. Moseson H, Herold S, Filippa S, Barr-Walker J, et al. Self-managed abor-
tion: a systematic scoping review. Best Pract Res Clin Obstet Gynecol. 
2020;63:87–110.
 19. Jensen KLB, Temple-Smith MJ, Bilardi JE. Health professionals’ roles and 
practices in supporting women experiencing miscarriage: a qualitative 
study. ANZJOG. 2019;59(4):508–13.
Page 10 of 10Raifman et al. BMC Women’s Health          (2021) 21:132 
•
 
fast, convenient online submission
 •
  
thorough peer review by experienced researchers in your field
• 
 
rapid publication on acceptance
• 
 
support for research data, including large and complex data types
•
  
gold Open Access which fosters wider collaboration and increased citations 
 
maximum visibility for your research: over 100M website views per year •
  At BMC, research is always in progress.
Learn more biomedcentral.com/submissions
Ready to submit your research ?  Choose BMC and benefit from: 
 20. Dedoose Version 8.0.35, web application for managing, analyzing, and 
presenting qualitative and mixed method research data. Los Angeles, CA: 
SocioCultural Research Consultants, LLC; 2018. http:// dedoo se. com/.
 21. Averill JB. Matrix analysis as a complementary analytic strategy in qualita-
tive inquiry. Qual Health Res. 2002;12(6):855–66.
 22. National Academies of Science, Engineering, and Medicine. The safety 
and quality of abortion care in the United States. Washington, DC: The 
National Academies Press; 2018.
 23. Harris LH, Grossman D. Complications of unsafe and self-managed abor-
tion. N Engl J Med. 2020;382(11):1029–40.
 24. Chong E, Frye L, Castle J, et al. A prospective, non-randomized study of 
home use of mifepristone for medical abortion in the U.S. Contraception. 
2015;92(3):215–9.
 25. Aiken ARA, Digol I, Trussell J, et al. Self-reported outcomes and adverse 
events after medical abortion through online telemedicine: population-
based study in the Republic of Ireland and Northern Ireland. BMJ. 
2017;357:j2011.
 26. Postabortion Care Consortium Community Task Force. Essential elements 
of postabortion care: an expanded and updated model. PAC in Action (2), 
Special Supplement. 2002.
 27. Dickens BM. Post-abortion care: ethical and legal duties. Int J Gynecol 
Obstet. 2019;147(2):273–8.
 28. McLemore M, Levi A. Nurses and care of women seeking abortions, 
1971–2011. J Obstet Gynecol Neonatal Nurs. 2011;40(6):672–7.
 29. Weigel G, Sobel L, Salganicoff A. Understanding pregnancy loss in the 
context of abortion restrictions and fetal harm laws, Kaiser Family Foun-
dation, Women’s Health Policy: Issue Brief. 2019.
 30. Grossman D, Baum SE, Andjelic D, et al. A harm-reduction model of 
abortion counseling about misoprostol use in Peru with telephone and 
in-person follow-up: a cohort study. PLoS ONE. 2018;13(1):e0189195.
 31. Paltrow LM, Flavin J. Arrests of and forced interventions on pregnant 
women in the United States, 1973–2005: implications for women’s legal 
status and public health. J Health Polit Policy Law. 2013;38:299–343.
 32. The American College of Obstetricians and Gynecologists (ACOG), Com-
mittee Opinion: Committee on Health Care for Underserved Women. 
Substance abuse reporting and pregnancy: the role of the obstetrician-
gynecologist, Number 473, January 2011, Reaffirmed 2019.
 33. The American College of Obstetricians and Gynecologists (ACOG), 
Committee on Ethics, Committee Opinion. Alcohol abuse and other sub-
stance use disorders: ethical issues in obstetric and gynecologic practice, 
Number 633. 2015.
 34. American Academy of Family Physicians. Position paper: preconception 
care. Leawood, KS: American Academy of Family Physicians, 2015. www. 
aafp. org/ about/ polic ies/ all/ preco ncept ion- care. html. Accessed 23 Aug 
2016.
 35. The American College of Obstetricians and Gynecologists (ACOG). 
Decriminalization of self-induced abortion: position statement. Approved 
by the Executive Board: December 2017, https:// www. acog. org/ Clini 
cal- Guida nce- and- Publi catio ns/ Posit ion- State ments/ Decri minal izati on- 
of- Self- Induc ed- Abort ion
 36. The American College of Obstetricians and Gynecologists (ACOG). 
Opposition to criminalization of individuals during pregnancy and the 
postpartum period: statement of policy. Approved by the Board of Direc-
tors: December 2020. https:// www. acog. org/ clini cal- infor mation/ policy- 
and- posit ion- state ments/ state ments- of- policy/ 2020/ oppos ition- crimi 
naliz ation- of- indiv iduals- pregn ancy- and- postp artum- period
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub-
lished maps and institutional affiliations.
